Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Better substances for treating the dengue virus

09.12.2014

Just like Ebola, dengue fever can be fatal. This disease is also caused by a virus for which there is currently no cure and no vaccine. Researchers from Mainz and Würzburg are now proposing potential new active substances.

In the quest for medication to treat the dengue virus, the scientific community is focusing on a particular enzyme of the pathogen, the protease known as NS2B/NS3. The reason for this is that inhibitors of similar proteases have been revealed to be very effective with other viruses. Protease inhibitors are already being used successfully in the treatment of HIV and Hepatitis patients.


The interactions of the protease inhibitor (yellow) with the enzyme were analyzed using computer-assisted methods. Image: Hongmei Wu

There are also several inhibitors for the dengue protease. However, at best, they stop only half of the viruses from multiplying, which is not enough for clinical applications. The Würzburg team led by virologist Jochen Bodem, in collaboration with scientists from the University of Mainz, has discovered far better inhibitors, which are now presented in the journal “Antimicrobial Agents and Chemotherapy”.

“We have developed seven good to very good inhibitors from the diaryl thioether class of molecules, and two of these are even really good,” says Bodem. When these two “stars” are used, only around three percent of the virus population in a cell culture survives even with very low concentrations of the active substance. From the point of view of science, this is a very good result, especially as the inhibitors, as desired, are highly specialist: they only target dengue viruses and have no impact whatsoever on very close relatives like the Hepatitis C virus.

The leading members of the team of researchers

The new active substances were developed by a team of virologists and pharmacists. From Mainz, Professor Tanja Schirmeister and, in particular, her colleague Hongmei Wu, were involved. Both conducted research at the University of Würzburg until a few years ago. Schirmeister’s team synthesized the inhibitors and then examined and further developed their interactions with the enzyme using computer-assisted methods.

On Jochen Bodem’s team, Stefanie Bock, who is now working towards a doctorate at the University of Münster, played a key role. Here the protease of the viruses was obtained and cleaned. The effect of the active substances on the dengue virus was later demonstrated in the safety laboratory. As a next step, the scientists will check whether the new active substances have negative effects on higher organisms and whether they inhibit viral replication there as well.

Dengue fever is spreading worldwide

Dengue fever originated in the tropics. However, for a few years now it has also been found in other warm regions of the world, such as the Mediterranean. Scientists are attributing this to climate change: the mosquitoes that transmit the virus to humans are able to expand their habitat thanks to increasing global warming.

The Robert Koch Institute reported on dengue fever in southern France and Croatia back in 2010. In Germany in 2013, there were a total of 879 recorded dengue patients – all travelers who had become infected in the southern hemisphere and in tropical countries. The World Health Organization estimates that the number of infections globally stands at 390 million a year. In 1970, infections occurred in just nine countries; these days, that figure has already risen to over 100.

Infection varies from asymptomatic to life-threatening

The virus is transmitted by the tiger mosquito and other mosquitoes. Usually the infection goes unnoticed since there are no signs of the disease in almost 90 percent of cases. In the remaining cases, an influenza-type illness develops, which may take a potentially fatal course, especially in children: in addition to muscle and bone pain accompanied by a high temperature for days, the patient then develops internal bleeding and other severe symptoms. Without intensive medical treatment, around half of these sufferers die.

To date, there is no vaccine and no way of fighting the dengue virus with specific drugs. It is therefore recommended that measures be taken to protect against mosquito bites in countries where there is a risk of infection; these include covering the skin with clothes as much as possible, sleeping under a mosquito net and applying mosquito-repellent creams.

“Novel Dengue virus NS2B/NS3 protease inhibitors”, Hongmei Wu, Stefanie Bock, Mariya Snitko, Thilo Berger, Thomas Weidner, Steven Holloway, Manuel Kanitz, Wibke E. Diederich, Holger Steuber, Christof Walter, Daniela Hofmann, Benedikt Weißbrich, Ralf Spannaus, Eliana G. Acosta, Ralf Bartenschlager, Bernd Engels, Tanja Schirmeister, and Jochen Bodem, Antimicrobial Agents and Chemotherapy, published online, December 8, 2014, doi:10.1128/AAC.03543-14

Contact

Dr. Jochen Bodem, Institute of Virology and Immunobiology at the University of Würzburg, T +49 (0)931 31-81509, jochen.bodem@vim.uni-wuerzburg.de

Prof. Dr. Tanja Schirmeister, Institute of Pharmacy and Biochemistry, University of Mainz, T +49 (0)6131 39-25742, schirmei@uni-mainz.de

Robert Emmerich | Julius-Maximilians-Universität Würzburg
Further information:
http://www.uni-wuerzburg.de

Further reports about: Chemotherapy Dengue Dengue fever Hepatitis NS3 dengue virus fever infections mosquito substances treating viruses

More articles from Life Sciences:

nachricht Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel

nachricht Smelling the forest – not the trees
12.12.2018 | Universität Konstanz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

New discoveries predict ability to forecast dementia from single molecule

12.12.2018 | Health and Medicine

CCNY-Yale researchers make shape shifting cell breakthrough

12.12.2018 | Physics and Astronomy

Pain: Perception and motor impulses arise in the brain independently of one another

12.12.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>